FDA Report on Postmarketing Requirements for Drug and Biologics Firms

Summary

The FDA is required to annually report on the status of postmarketing studies and clinical trials for approved drug and biologics products, as mandated by the 1997 Modernization Act, and this report details the Agency's findings.